Henrik Schinke

Clinical robustness of CSF pTau/Aβ42 ratio for Alzheimer’s disease diagnosis 5:21
Clinical robustness of CSF pTau/Aβ42 ratio for Alzheimer’s disease diagnosis
Henrik Schinke • 15 Dec 2022
Remaining challenges in bringing fluid biomarkers into clinical practice 2:07
Remaining challenges in bringing fluid biomarkers into clinical practice
Henrik Schinke • 15 Dec 2022
Bringing the pTau/Aβ42 biomarker into the clinic 1:49
Bringing the pTau/Aβ42 biomarker into the clinic
Henrik Schinke • 15 Dec 2022
The content of VJDementia is intended for healthcare professionals